ICD-10-CM Billable Code

F12.180

Cannabis abuse with cannabis-induced anxiety disorder

Clinical Classification Guidelines

Medical Intelligence & Overview

Cannabis abuse with cannabis-induced anxiety disorder is a condition that involves problematic use of cannabis alongside significant anxiety symptoms triggered by the substance. This condition reflects both dependency issues and mental health challenges directly associated with cannabis consumption. Recognizing and understanding this combination can help individuals and their loved ones better manage the disorder and seek appropriate help when necessary.

Causes & Symptoms

Clinical Causes: Repeated or excessive use of cannabis leading to dependency Genetic factors that influence response to cannabis and susceptibility to addiction Mental health history, including anxiety or mood disorders, increasing vulnerability Environmental stressors or peer pressure encouraging substance use Use of cannabis at a young age, impacting brain development

Key Symptoms: Persistent desire or unsuccessful attempts to cut down cannabis use Spending a significant amount of time obtaining, using, or recovering from cannabis effects Craving or strong urge to consume cannabis Neglecting responsibilities at work, school, or home due to cannabis use Continued use despite social or interpersonal problems caused or worsened by cannabis Development of anxiety symptoms such as nervousness, restlessness, or irritability during or after cannabis use Experiencing sudden episodes of intense anxiety or panic attacks related to cannabis consumption Physical symptoms like rapid heartbeat, sweating, or trembling during anxiety episodes

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive assessment by a healthcare professional, including detailed history of cannabis use, evaluation of anxiety symptoms, and ruling out other causes of anxiety. Diagnostic criteria outlined in clinical guidelines are used to confirm the presence of cannabis abuse alongside cannabis-induced anxiety disorder. Possible interviews and questionnaires may be employed to gauge the extent of substance use and mental health symptoms.

Treatment Protocols: Managing this disorder typically involves a combination of approaches tailored to the individual's needs. Treatment options may include behavioral therapies such as cognitive-behavioral therapy (CBT) to address substance dependence and anxiety symptoms. Support groups and counseling can provide additional support. In some cases, medication may be prescribed to alleviate anxiety symptoms or manage withdrawal effects, but these should always be considered and monitored by a healthcare professional. Long-term strategies often emphasize developing healthier coping mechanisms and avoiding cannabis use to reduce relapse risk.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F12.180 a billable ICD-10 code?
Yes, F12.180 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F12.180?
Clinical documentation must specify the nature of Cannabis abuse with cannabis-induced anxiety disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference